Antiespumantes e Controle de Espuma Produtos Químicos

Antifoams are added to a formulation before foaming occurs to prevent bubble formation (prophylactic action). Defoamers destroy existing foam once it has formed (curative action). In practice, most commercial products combine both mechanisms. The distinction matters for dosage timing: antifoams are added during let-down; defoamers are used in the grinding stage and may be split-dosed at let-down to address foam generated at both production stages.

Silicone defoamers work by spreading rapidly across bubble surfaces, causing film rupture. However, if the silicone droplets are too large, incompatible with the binder, or added at the wrong stage, they migrate to the coating surface, creating wax-like spots or craters (fisheyes). Prevention: use silicone defoamers in emulsified or polymer-modified form, dose at the grinding stage for maximum distribution, and verify compatibility with the binder system through drawdown testing. Overtreatment is common — use the minimum effective dosage.

For waterborne architectural coatings, mineral oil defoamers or polymer-based (polyacrylate, polyether) defoamers are preferred over straight silicone to avoid intercoat adhesion issues. Key selection criteria: (1) HLB compatibility with the surfactant package; (2) stability in freeze-thaw cycles; (3) shear stability during high-speed dispersion; (4) compatibility with HEUR/HASE rheology modifiers (some defoamers disrupt associative thickener networks). Dosage is typically 0.1–0.5% on total formulation weight.